(EMAILWIRE.COM, September 11, 2018 ) Growth in US pediatric vaccine market can be attributed to factors such as increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccine development.

The research report titled “United States Pediatric Vaccine Market 2017 – Demand, Insights, Analysis, Opportunities Segmentation and Forecast to 2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States pediatric vaccine market.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-DPI-HnM-3141

The report concludes with the profiles of major players in the United States pediatric vaccine market. The key market players are evaluated on various parameters such as company overview, pediatric vaccine portfolios and latest development & trends of the pediatric vaccine market.


The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues and provides forecasts through 2024. The report also provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccine market.

Purchase Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-DPI-HnM-3141/ (Priced at USD 850)

Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:

Diphtheria, Tetanus & Pertussis (DTap)
Hepatitis A
Varicella/Chicken Pox
Pneumococcal
Haemophilus Influenzae Type B (HIB)
Polio
Rotavirus
Hepatitis B
Influenza Pediatric
Measles, Mumps & Rubella (MMR)


Key Deliverables in the Study

Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
It provides a growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed based on how the market is predicted to grow
It helps in understanding the key product segments and their future
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
A comprehensive list of key market players along with the analysis of their current pediatric vaccines portfolios and latest development and trends.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-DPI-HnM-3141

Table of Content:

1. Executive Summary
2. Market Size & Analysis: United States Pediatric Vaccine (2010 – 2024)
3. United States Pediatric Vaccine Market Share and Y–o–Y Growth (%)
4. Key Market Drivers and Inhibitors of the United States Pediatric Vaccine Market
4.1 Market Drivers
4.2 Market Inhibitors
5. United States Pediatric Vaccine Market – By Disease Indication (2010 – 2024)
5.1 Diphtheria, Tetanus & Pertussis (DTap)
6. Key Companies Analysis
6.1 Sanofi Pasteur
6.2 Business Overview
6.1 Pediatric Vaccine Portfolios
6.2Pedaitric Vaccine – Latest Development & Trends

Enquiry for Customization@ https://www.qurateresearch.com/report/customize/HnM/QBI-DPI-HnM-3141

List of Figures:

Figure 2–1: United States Pediatric Vaccine Market (Million US$), 2010 – 2016
Figure 2–2: United States Pediatric Vaccines Market Forecast (Million US$), 2017 – 2024
Figure 4–19: DTap Vaccine Doses Administered (in Million), 2010 – 2016
Figure 4–20: DTap Vaccine Doses Administered Forecast (in Million), 2017 – 2024
Figure 4–21: Number of Children Being Vaccinated with DTap Vaccine (in Million),2010 – 2016

Contact Information:
Qurate Business Intelligence
Nehal Chinoy
Tel: +919881074592
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results